Biểu đồ giá cổ phiếu CNTB
CNTB Cổ tức
Connect Biopharma Holdings Ltd
$2.48
0.4%
$0
Khi đóng cửa: May 06, 16:00:00 GMT-4
$2.52
1.61%
$0.04
Phiên sau giờ: May 06, 20:00:00 GMT-4
Quay lại
Connect Biopharma Holdings Ltd (CNTB) Cổ tức
Thống kê chính
Giá đóng cửa trước
$2.47
Giá mở cửa
$2.49
Phạm vi ngày
$2.44 - $2.55
Phạm vi 52 tuần
$0.6 - $3.82
Khối lượng
67.4K
Khối lượng trung bình
189.1K
Tỷ suất cổ tức
--
EPS (TTM)
-0.81
Vốn hóa thị trường
$140.4M
CNTB là gì?
Connect Biopharma Holdings Ltd. operates as clinical-stage biopharmaceutical company. The company is headquartered in San Diego, California and currently employs 62 full-time employees. The company went IPO on 2021-03-19. The firm is focused on advancing rademikibart, a potentially best-in-class next generation anti-interleukin-4-receptor alpha (IL-4Rα) antibody, to transform acute and chronic care in asthma and chronic obstructive pulmonary disease (COPD). Its lead product candidate, rademikibart, is an antibody designed to target interleukin-4 receptor alpha (IL-4Rα) in development for the treatment of atopic dermatitis (AD) and asthma. As an inhibitor of IL-4Rα, rademikibart blocks inflammatory signaling by both IL-4 and IL-13. The firm has completed a global Phase II trial (CBP-201-WW001) of rademikibart in adult patients with moderate-to-severe AD.
